Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yongjian Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0169-6073; OpenAlex author ID A5085826663. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2013: 2 papers · 2014: 3 papers · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 13

  1. Mesoporous High-Entropy Oxides Nanoplatform Decodes Paired-Plasma Metabolic Fingerprinting of Pancreatic Cancer. Co-author DOI 10.1002/adma.202513988↗
  2. The development and validation of biomarkers-based scoring systems for predicting early recurrence in patients with borderline resectable pancreatic cancer und… Co-author DOI 10.21037/gs-2024-500↗
  3. Recurrence scoring system predicting early recurrence for patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy and portomesenteric vein res… Co-author DOI 10.4240/wjgs.v16.i10.3185↗
  4. WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41416-020-0929-0↗
  5. Blood-based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Pancreatic Cancer and its Value to Guide Clinical Treatment. Co-author DOI 10.7150/jca.43087↗
  6. Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probe. Co-author DOI 10.1016/j.biomaterials.2016.11.006↗
  7. Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein invo… Co-author DOI 10.18632/oncotarget.20847↗
  8. Role of immune cells in pancreatic cancer from bench to clinical application: An updated review. First author DOI 10.1097/md.0000000000005541↗
  9. FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis. Co-author DOI 10.1371/journal.pone.0106741↗
  10. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel. Co-author DOI 10.3748/wjg.v20.i28.9476↗
  11. MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Co-author DOI 10.4161/cbt.29706↗
  12. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Co-author DOI 10.1007/s12032-013-0700-y↗
  13. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. Co-author DOI 10.3892/or.2013.2516↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Jin · 8 shared papers, 2013–2025 · strength 0.83
  2. Feng Yang · 8 shared papers, 2013–2025 · strength 0.77
  3. Hang He · 7 shared papers, 2013–2025 · strength 0.77
  4. Deliang Fu · 10 shared papers, 2013–2024 · strength 0.76
  5. Yonghui Deng · 2 shared papers, 2017–2026 · strength 0.37
  6. Ji Li · 3 shared papers, 2013–2024 · strength 0.36
  7. Lie Yao · 5 shared papers, 2013–2020 · strength 0.34
  8. Yue Sun · 1 shared paper, 2026 · strength 0.32
  9. De-Liang Fu · 1 shared paper, 2025 · strength 0.27
  10. Jichun Gu · 3 shared papers, 2017–2020 · strength 0.26
  11. Di Yang · 5 shared papers, 2013–2020 · strength 0.26
  12. Hengchao Li · 3 shared papers, 2017–2020 · strength 0.25
  13. Ji Li · 3 shared papers, 2014–2020 · strength 0.21
  14. Venu Gopal Pillarisetty · 2 shared papers, 2014–2016 · strength 0.14
  15. Yishen Mao · 1 shared paper, 2020 · strength 0.10
  16. Xiaohui Liu · 1 shared paper, 2020 · strength 0.10
  17. Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.10
  18. Pengyuan Yang · 1 shared paper, 2020 · strength 0.10
  19. Jae Hyuck Chang · 1 shared paper, 2016 · strength 0.10
  20. Chong-Lek Lee · 2 shared papers, 2013–2014 · strength 0.09
  21. Sijie Hao · 2 shared papers, 2013–2014 · strength 0.08
  22. Yifan Zhang · 1 shared paper, 2017 · strength 0.07
  23. Zhibo Xie · 1 shared paper, 2017 · strength 0.07
  24. Dongyuan Zhao · 1 shared paper, 2017 · strength 0.06
  25. Qiang Wang · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.